Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Frontiers in Immunology|December 19, 2022
COVID-19 vaccination and Atypical hemolytic uremic syndromeRomy N Bouwmeester, Esther M G Bormans, Caroline Duineveld, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 21, 2023
Cryoglobulinemic Vasculitis in Disguise: Cryofibrinogenemia as Variant of Monoclonal Gammopathy of Renal SignificanceChristina M Gant, Carin A Koelman, Tri Q Nguyen, et al.Kidney International Reports|April 18, 2023
Eculizumab Rescue Therapy in Patients With Recurrent Atypical Hemolytic Uremic Syndrome After Kidney TransplantationCaroline Duineveld, Romy N Bouwmeester, Kioa L Wijnsma, et al.Clinical Journal of the American Society of Nephrology : CJASN|March 13, 2023
Proteinuria and Exposure to Eculizumab in Atypical Hemolytic Uremic SyndromeMendy Ter Avest, Hilbert Steenbreker, Romy N Bouwmeester, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 3, 2022
Proposal for individualized dosing of eculizumab in atypical haemolytic uraemic syndrome: patient friendly and cost-effectiveMendy Ter Avest, Romy N Bouwmeester, Caroline Duineveld, et al.Frontiers in Immunology|August 30, 2021
Different Aspects of Classical Pathway Overactivation in Patients With C3 Glomerulopathy and Immune Complex-Mediated Membranoproliferative GlomerulonephritisMarloes A H M Michels, Nicole C A J van de Kar, Sanne A W van Kraaij, et al.Clinical Chemistry and Laboratory Medicine|January 2, 2026
Laboratory findings in patients treated with complement factor C3 inhibitor pegcetacoplanSaskia M C Langemeijer, Jeroen D Langereis, Mendy Ter Avest, et al.Kidney International Reports|June 19, 2026
Atypical Hemolytic Uremic Syndrome in Children and Adults With the Hot Spot C3 Gene Variant p.Arg161TrpLieke Ter Steeg, Romy N Bouwmeester, Mendy Ter Avest, et al.Kidney International Reports|January 16, 2023
Early Eculizumab Withdrawal in Patients With Atypical Hemolytic Uremic Syndrome in Native Kidneys Is Safe and Cost-Effective: Results of the CUREiHUS StudyRomy N Bouwmeester, Caroline Duineveld, Kioa L Wijnsma, et al.Pageof 2